Nasdaq

By: Sara Warden 2 min read December 2019 — The biotech industry is unlike almost any other. Companies spend billions of dollars in drug development that can end in failure, generate little to no revenue but can still be worth billions of dollars. According to Toptal Finance, almost 80% of the